Search - tctmd.com

Displaying 161 - 180 of 208

Sort: Relevancy | Date

News Daily News

Anthracycline-Based Chemotherapy Linked to Valve Disease, Even in Absence of Radiation

L.A. McKeown

February 16, 2016

News Conference News AHA 2015

Inappropriate PCIs Slashed by Half Since First AUC Released, But Key Questions Remain

Shelley Wood

November 08, 2015

News Industry News

St. Jude Medical Announces CE Mark Approval for the HeartMate 3 Left Ventricular Assist System

October 12, 2015

Presentation TCT 2015

ACS Intervention in Patients With Orthotopic Heart Transplantation

Presenter: Bagrat Alekyan, Juan F. Granada, Vladimir Ganyukov

October 11, 2015

News Industry News

Sunshine Heart to Present Hemodynamic Data Supporting Mechanism of Action of the C-Pulse System at 2015 Transcatheter Cardiovascular Therapeutics Conference

October 08, 2015

News Industry News

HeartWare Completes Enrollment In ENDURANCE2 Supplemental Destination Therapy Trial

August 10, 2015

News Industry News

Thoratec Announces First HeartMate 3™ Implant in European Less Invasive Surgical Trial

July 07, 2015

News Featured Fellow

Jesse Naghi, MD

Yael L. Maxwell

June 11, 2015

News Industry News

Global Cardiovascular Drug Delivery Market 2015 - Technologies, Markets and Companies

May 28, 2015

Presentation CATCH-UP 2015

Heart Transplantation What does the future hold?

Presenter: Donna Mancini

April 24, 2015

News Conference News ACC 2015

Small Study Suggests Benefits of Denervation for Pulmonary Arterial Hypertension

Todd Neale

March 17, 2015

News Conference News ACC 2015

ERICCA: Remote Ischemic Preconditioning Fails to Improve Long-Term Outcomes After CABG

Yael L. Maxwell

March 16, 2015

News Industry News

Sanofi and MyoKardia Announce Groundbreaking Collaboration to Develop Targeted Therapies for Patients with Genetic Heart Disease

September 17, 2014

News Industry News

Thoratec Announces Start Of Heartmate III™ U.S. Clinical Trial

September 09, 2014

News Industry News

Thoratec Announces First HeartMate III™ Human Implant And Start Of CE Mark Trial

June 27, 2014

News Industry News

Abiomed Surpasses 20,000 Impella Patients in the United States

June 03, 2014

News Industry News

Novartis provides update on EU marketing authorization application for RLX030 in acute heart failure

May 23, 2014

News Daily News

Preclinical Study Casts Doubt on Regenerative Ability of Special Cardiac Stem Cells

May 12, 2014

News Daily News

Meta-analysis: Bone Marrow Mononuclear Cell Therapy Fails to Show Efficacy in Acute MI

Yael L. Maxwell

April 08, 2014

News Conference News ACC 2014

Intramyocardial Injection of Stem Cells Shows Promise for Severe Ischemic Heart Failure

Yael L. Maxwell

March 31, 2014

Advertisement

Anthracycline-Based Chemotherapy Linked to Valve Disease, Even in Absence of Radiation

Inappropriate PCIs Slashed by Half Since First AUC Released, But Key Questions Remain

St. Jude Medical Announces CE Mark Approval for the HeartMate 3 Left Ventricular Assist System

ACS Intervention in Patients With Orthotopic Heart Transplantation

Sunshine Heart to Present Hemodynamic Data Supporting Mechanism of Action of the C-Pulse System at 2015 Transcatheter Cardiovascular Therapeutics Conference

HeartWare Completes Enrollment In ENDURANCE2 Supplemental Destination Therapy Trial

Thoratec Announces First HeartMate 3™ Implant in European Less Invasive Surgical Trial

Jesse Naghi, MD

Global Cardiovascular Drug Delivery Market 2015 - Technologies, Markets and Companies

Heart Transplantation What does the future hold?

Small Study Suggests Benefits of Denervation for Pulmonary Arterial Hypertension

ERICCA: Remote Ischemic Preconditioning Fails to Improve Long-Term Outcomes After CABG

Sanofi and MyoKardia Announce Groundbreaking Collaboration to Develop Targeted Therapies for Patients with Genetic Heart Disease

Thoratec Announces Start Of Heartmate III™ U.S. Clinical Trial

Thoratec Announces First HeartMate III™ Human Implant And Start Of CE Mark Trial

Abiomed Surpasses 20,000 Impella Patients in the United States

Novartis provides update on EU marketing authorization application for RLX030 in acute heart failure

Preclinical Study Casts Doubt on Regenerative Ability of Special Cardiac Stem Cells

Meta-analysis: Bone Marrow Mononuclear Cell Therapy Fails to Show Efficacy in Acute MI

Intramyocardial Injection of Stem Cells Shows Promise for Severe Ischemic Heart Failure

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content